Works by Maria Elli, Elena
Results: 23
Breakthrough infections in MPN-COVID vaccinated patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00749-8
- By:
- Publication type:
- Article
Long-term follow-up of recovered MPN patients with COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00392-1
- By:
- Publication type:
- Article
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01186
- By:
- Publication type:
- Article
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 1, p. 105, doi. 10.1007/s00277-020-04306-w
- By:
- Publication type:
- Article
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 123, doi. 10.1002/hon.2808
- By:
- Publication type:
- Article
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 2, p. 190, doi. 10.1111/bjh.18057
- By:
- Publication type:
- Article
Second cancers in MPN: Survival analysis from an international study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 295, doi. 10.1002/ajh.25700
- By:
- Publication type:
- Article
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 692, doi. 10.1002/ajh.24382
- By:
- Publication type:
- Article
Biosimilar erythropoiesis‐stimulating agents are an effective and safe option for the management of myelofibrosis‐related anemia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 4, p. 354, doi. 10.1111/ejh.13910
- By:
- Publication type:
- Article
Management of polycythemia vera: A survey of treatment patterns in Italy.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 161, doi. 10.1111/ejh.13889
- By:
- Publication type:
- Article
Neurological symptoms in essential thrombocythemia: impact of JAK2 V617 F mutation and response to therapy.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 6, p. 593, doi. 10.1111/ejh.12638
- By:
- Publication type:
- Article
From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.752192
- By:
- Publication type:
- Article
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1799, doi. 10.3390/cancers14071799
- By:
- Publication type:
- Article
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.668261
- By:
- Publication type:
- Article
Neutrophil‐to‐lymphocyte ratio (NLR) at diagnosis in essential thrombocythemia: A new promising predictor of thrombotic events.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35638
- By:
- Publication type:
- Article
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 11, p. 1704, doi. 10.1002/cncr.34722
- By:
- Publication type:
- Article
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1462, doi. 10.1002/ajh.27418
- By:
- Publication type:
- Article
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID‐19.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E470, doi. 10.1002/ajh.26732
- By:
- Publication type:
- Article
Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution.
- Published in:
- Virus Evolution, 2022, v. 8, n. 1, p. 1, doi. 10.1093/ve/veac026
- By:
- Publication type:
- Article